Rodent studies support these clinical findings and have reported impairments in HPA axis function following MS, including altered CRH, ACTH, and CORT levels, as well as decreases in hippocampal GR expression that last into adulthood (Figs. 1B and 2F) [124–126]. The gene discussed is NR3C1; the disease is myeloid sarcoma.